Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
5, 2025 /PRNewswire/ -- Novo Nordisk today announced the filing of 14 new lawsuits to safeguard patients from unsafe and unapproved compounded drugs claiming to contain "semaglutide." The defendants named in these lawsuits employ tactics that deceive patients into believing compounded products have been reviewed and approved by FDA or have equivalent safety or effectiveness as Novo Nordisk's approved semaglutide medicines
DiamondGlow has your back here, too
But as a commercially scalable model, compounded GLP-1 distribution is functionally over
In double-blind studies, neither participants nor doctors know who receives the placebo or the active medication
US$ 26.52
US$ 20.23
US$ 27.01
US$ 26.85
US$ 26.28
US$ 26.20
US$ 27.08
